Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.49 |
| ▸ | KDM1A | O60341 | 2/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2053269 | 0.88 | NQO1 (0.52) | TUBB1KDM1AKDM4EL3MBTL1FFAR1 | |
| SCHEMBL15295257 | 0.85 | MTNR1A (0.47) | TUBB1CA12CA1CA2CA7 | |
| SCHEMBL8361639 | 0.85 | L3MBTL1 (0.46) | CA12CA1CA2CA7CA9 | |
| SCHEMBL18361620 | 0.85 | TUBB1 (0.53) | TUBB1CALM1MAPTKDM4EGAA | |
| SCHEMBL12093386 | 0.85 | HTT (0.47) | TUBB1CA12CA1CA2CA7 | |
| SCHEMBL1510002 | 0.84 | KDM1A (0.45) | TUBB1KDM1AMAPTKDM4EL3MBTL1 | |
| SCHEMBL16855928 | 0.83 | PRKCZ (0.44) | TUBB1CA12CA1CA2CA7 | |
| SCHEMBL4630357 | 0.83 | CA12 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL177773 | 0.81 | KDM1A (0.46) | TUBB1KDM1AMAPTKDM4EL3MBTL1 | |
| SCHEMBL6349213 | 0.81 | KDM1A (0.46) | TUBB1KDM1AMAPTKDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9394272-B2 | 1,3-dioxane compound having fluorine atom in axial position, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2016-07-19 | — | — | US | disclosed |
| US-20150368225-A1 | 1,3-DIOXANE COMPOUND HAVING FLUORINE ATOM IN AXIAL POSITION, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368225-A1 | 1,3-DIOXANE COMPOUND HAVING FLUORINE ATOM IN AXIAL POSITION, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CXCR1, HAX1, RCC1 | TUBB1 3546/4885KDM1A 653/4885CA12 739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.